Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture vs morphine for dyspnoea in non-small cell lung cancer
2006-000810-18Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of morphine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Primary dyspnoea improvement. Started Mar 2006; status: completed.
02
Drugs
morphine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2006-000810-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000810-18.